跳转至内容
Merck

1.00419

SAFC

Parteck® M 200(甘露醇)

EMPROVE® ESSENTIAL, Ph. Eur., ChP, JP, USP, E 421

制药生产

别名:

D-甘露醇

登录查看公司和协议定价


About This Item

经验公式(希尔记法):
C6H14O6
CAS号:
分子量:
182.17
MDL號碼:
分類程式碼代碼:
12352201
酶號碼:
E421
酶委員會索引編號:
200-711-8

agency

BP
ChP
JP
Ph. Eur.
USP

品質等級

產品線

EMPROVE® ESSENTIAL

形狀

fine powder

自燃溫度

410 °C

品質

E 421

粒徑

(see specification)

bp

290-295 °C/4 hPa

mp

164-169 °C

溶解度

213 g/L

應用

liquid formulation
pharmaceutical
solid formulation

儲存溫度

2-25°C

InChI

1S/C6H14O6/c7-1-3(9)5(11)6(12)4(10)2-8/h3-12H,1-2H2

InChI 密鑰

FBPFZTCFMRRESA-UHFFFAOYSA-N

正在寻找类似产品? 访问 产品对比指南

一般說明

With formulation challenges in mind, we have used particle engineering technologies to develop functional excipients specifically for solid dosage forms. The products in our Parteck® portfolio feature unique particle properties tailored for excellent performance in tableting processes, for specific drug delivery technologies, or for solubility enhancement.
As part of our Emprove® Program, our raw materials are offered with extensive documentation facilitating compliance of your pharma and biopharma product, full supply chain transparency and risk mitigation. Our SAFC® portfolio of high-quality products for biopharmaceutical and pharmaceutical formulation and production withstands strict quality control procedures and is produced according to applicable cGMP guidelines.

應用

Parteck® M excipient achieves excellent compressibility while keeping the API stable throughout your manufacturing process and beyond. Based on directly compressible mannitol, it does not require further processing or high compression forces. The unique and large surface area of Parteck® M excipient enables rapid disintegration and quick release regardless of the dosage. It is well suitable for tableting processesusing direct compression or granulation techniques such as wet granulation androller compaction. Parteck® M is available in different particle sizes.
The specification of the product is part of the Emprove® Material Qualification Dossier and can be found under "General Properties".

特點和優勢

  • High compactibility at low compression forces
  • Rapid disintegration and fast dissolution
  • High dilution potential
  • Non-hygroscopic, exceptionally low content of reducing sugars
  • Uniform doses with homogenous distribution

法律資訊

Emprove is a registered trademark of Merck KGaA, Darmstadt, Germany
PARTECK is a registered trademark of Merck KGaA, Darmstadt, Germany
SAFC is a registered trademark of Merck KGaA, Darmstadt, Germany

儲存類別代碼

11 - Combustible Solids

水污染物質分類(WGK)

WGK 1


分析证书(COA)

输入产品批号来搜索 分析证书(COA) 。批号可以在产品标签上"批“ (Lot或Batch)字后找到。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

其他客户在看

Slide 1 of 2

1 of 2

商品

In recent years, mannitol has gained popularity as an excipient in solid dosage formulation due to its beneficial physicochemical properties.

This article describes the advantages of mannitol when used as an excipient in solid drug formulation.

Learn about common tablet manufacturing technologies and the advantages and disadvantages of each.

Our overview of API solubility and dissolution enhancement methods can help you decide between the many options to take during formulation.

查看所有结果

相关内容

Developing formulations specifically for infants and children is increasingly important. To help you master these challenges effectively, we offer an extensive portfolio of well-established high-quality excipients and APIs for pediatric pharmaceutical formulations that are proven in practice.

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门